Provided by Tiger Trade Technology Pte. Ltd.

Dynavax

10.79
+0.01000.09%
Pre-market: 10.60-0.1900-1.76%04:37 EST
Volume:1.72M
Turnover:18.64M
Market Cap:1.27B
PE:-30.02
High:11.02
Open:10.79
Low:10.63
Close:10.78
52wk High:14.63
52wk Low:9.20
Shares:117.42M
Float Shares:98.91M
Volume Ratio:1.27
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3595
EPS(LYR):0.2100
ROE:-7.14%
ROA:1.20%
PB:2.37
PE(LYR):51.38

Loading ...

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dow Jones
·
Dec 02

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.
·
Nov 25

Dynavax Technologies to Join Evercore Healthcare Conference

Reuters
·
Nov 20

Should Dynavax Technologies' (DVAX) $100 Million Buyback and Guidance Update Prompt a Reassessment by Investors?

Simply Wall St.
·
Nov 18

Exploring Dynavax Technologies (DVAX) Valuation Following Q3 Earnings Growth and $100M Buyback Announcement

Simply Wall St.
·
Nov 11

Dynavax Technologies Up Over 7%, on Pace for Largest Percent Increase Since November 2024 -- Data Talk

Dow Jones
·
Nov 07

Evercore ISI Reaffirms Their Buy Rating on Dynavax (DVAX)

TIPRANKS
·
Nov 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dynavax (DVAX) and QuidelOrtho (QDEL)

TIPRANKS
·
Nov 06

Vaxart Partners with Dynavax for Oral COVID-19 Vaccine

TIPRANKS
·
Nov 06

Dynavax reports Q3 HEPLISAV-B net product revenue of $90 million and announces $100 million share repurchase program

Reuters
·
Nov 06

Dynavax Technologies Q3 EPS $0.21 Beats $0.12 Estimate, Sales $94.876M Beat $94.003M Estimate

Benzinga
·
Nov 06

Vaxart Secures $30 Million From Dynavax for Oral COVID-19 Vaccine License

Reuters
·
Nov 06

Vaxart Inc - to Receive $25 Mln Upfront and $5 Mln Equity Investment

THOMSON REUTERS
·
Nov 06

Vaxart Inc - May Receive up to $195 Mln in Regulatory Milestones

THOMSON REUTERS
·
Nov 06

Vaxart Inc - Dynavax to Pay Additional $50 Mln Fee to Vaxart

THOMSON REUTERS
·
Nov 06

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral Covid-19 Vaccine Program

THOMSON REUTERS
·
Nov 06

How Strong Z-1018 Shingles Vaccine Data at Dynavax Technologies (DVAX) Has Changed Its Investment Story

Simply Wall St.
·
Nov 02

High Growth Tech Stocks In US Market

Simply Wall St.
·
Oct 28

Dynavax Technologies (DVAX) Is Up 5.7% After Positive Z-1018 Shingles Vaccine Data Release – Has The Bull Case Changed?

Simply Wall St.
·
Oct 25

Dynavax Technologies Corporation to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 23